Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese Residents
Antibiotics · 12.07.2025 · 14 (7) · 701
DOI: 10.3390/antibiotics14070701 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Antibiotics, online erschienen am 12.07.2025. Verfasst von Guo Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) represents a critical global health threat, with inappropriate antibiotic self-medication (ASM) being a key contributor. China—as the world’s largest antibiotic consumer—faces significant challenges despite regulatory efforts, compounded by limited contemporary data during the COVID-19 pandemic. A nationwide cross-sectional study was conducted using the 2021 China Family Health Index Survey (n = 11,031 participants across 120 cities). Trained investigators administered face-to-face questionnaires assessing ASM practices, decision-making factors, and sociodemographic characteristics. Multivariate logistic regression identified determinants of ASM. Overall, ASM prevalence was 33.7% (n = 3717), with no urban-rural difference (p > 0.05). Physician advice (78.2%), drug safety (67.1%), and efficacy (64.2%) were primary selection criteria; rural residents prioritized drug price and salesperson recommendations more than their urban counterparts (p < 0.01). Key predictors included higher ASM odds among females (OR = 1.30, 95%CI:1.18–1.43), middle-aged adults (46–59 years; OR = 1.20, 95%CI:1.02–1.42), those with health insurance (resident: OR = 1.33; commercial: OR = 1.62), and individuals with drinking histories (OR = 1.20, 95%CI:1.10–1.31). Lower odds were associated with primary education (OR = 0.69, 95%CI:0.58–0.81), unemployment (OR = 0.88, 95%CI:0.79–0.98), and absence of chronic diseases (OR = 0.56, 95%CI:0.47–0.67). One-third of Chinese residents engaged in ASM during the pandemic, driven by intersecting demographic and behavioral factors. Despite converging urban-rural prevalence rates, distinct decision-making drivers necessitate context-specific interventions, including strengthened pharmacy regulation in rural areas, tailored education programs for high-risk groups, and insurance system reforms to disincentivize self-medication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- International Research Center for Medicinal Administration, Peking University, Beijing 100191, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
- Division of Chronic Non-Communicable Diseases and Injury Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 201106, China.
ORCID-Profile: Guo Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, G., Ge, P., Sui, M., Zhu, H., Han, S., & Shi, L. (2025). Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese Residents. Antibiotics, 14(7), 701. https://doi.org/10.3390/antibiotics14070701
Vancouver
Huang G, Ge P, Sui M, Zhu H, Han S, Shi L. Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese Residents. Antibiotics. 2025;14(7):701. doi:10.3390/antibiotics14070701
BibTeX
@article{Huang2025,
author = {Huang, Guo and Ge, Pu and Sui, Mengyun and Zhu, He and Han, Sheng and Shi, Luwen},
title = {Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese Residents},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {7},
pages = {701},
doi = {10.3390/antibiotics14070701}
}
EUVIMED